Monthly Archives: February 2026

Unusual Amino Acids: 2,4-Diaminobutyric Acid (DAB)

Posted on by
Dab

2,4-Diaminobutyric acid (DAB) is a fascinating non-proteinogenic diamino acid that has garnered significant attention in peptide chemistry and biomedical research. Structurally characterized by the presence of two amino groups at the alpha and gamma positions of a four-carbon backbone, this unusual amino acid serves as a versatile building block for creating peptides with unique structural and functional properties. Unlike standard amino acids encoded by the genetic code, DAB must be incorporated into peptides through specialized synthetic strategies, making it a valuable tool for researchers seeking to introduce additional charge, hydrogen-bonding capacity, or conformational constraints into their peptide sequences. Its biological significance extends beyond synthetic utility, as DAB occurs naturally in various organisms and exhibits interesting pharmacological activities, including interactions with neurotransmitter systems and potential anticancer properties.

Key Takeaways

  • 2,4-Diaminobutyric acid (DAB) is a non-proteinogenic diamino acid with the molecular formula C4H10N2O2 and a structure featuring amino groups at both the 2-position (alpha) and 4-position (gamma) of the butyric acid backbone.
  • DAB exists as two stereoisomers, L-DAB and D-DAB, which exhibit markedly different biological activities. The S(+) isomer is at least 20 times more potent than the R(-) isomer at inhibiting GABA uptake in neuronal tissues.
  • In peptide synthesis, DAB requires orthogonal protecting group strategies, commonly using derivatives like Dde-DAB(Fmoc)-OH, to enable selective deprotection and site-specific functionalization during solid-phase peptide synthesis.
  • DAB-containing peptides have demonstrated antitumoral activity against human glioma cells, attributed to concentrated uptake leading to osmotic cellular lysis.
  • The incorporation of DAB into cyclic dipeptides enables the formation of conformationally constrained structures, such as 5-membered lactam rings, which are valuable for studying protein structure-function relationships.

Chemical Fundamentals of 2,4-Diaminobutyric Acid

Definition and Structural Characteristics of DAB

2,4-Diaminobutyric acid is formally defined as a diamino acid derived from butyric acid, wherein hydrogen atoms at positions 2 and 4 are replaced by amino groups. Its molecular formula is C4H10N2O2, with an average mass of 118.13 g/mol. The compound features an alpha amino group adjacent to the carboxylic acid and a gamma amino group at the end of the aliphatic chain, creating a structure with two positively charged centers at physiological pH. This dual cationic character distinguishes DAB from standard amino acids and imparts unique physicochemical properties, including enhanced water solubility and the ability to participate in multiple hydrogen-bonding interactions.

Isomeric Forms and Stereochemistry

A critical aspect of DAB chemistry is its existence as two distinct stereoisomers due to the chiral center at the alpha carbon. The L-isomer (S-configuration) and D-isomer (R-configuration) exhibit profound differences in their biological activities. Research has demonstrated that S(+)-2,4-diaminobutyric acid is approximately 20 times more potent than the R(-) stereoisomer as an inhibitor of sodium-dependent GABA uptake in rat brain slices. Interestingly, both isomers display equipotent inhibition of sodium-independent GABA binding to brain membranes, suggesting that the stereospecificity relates specifically to transporter interactions rather than receptor binding. This stereochemical discrimination underscores the importance of using the correct isomer when designing DAB-containing peptides for neurobiological applications.

Find out more about peptide synthesis here.

DAB Applications in Peptide Synthesis

Orthogonal Protection Strategies

The incorporation of DAB into synthetic peptides presents unique challenges due to the presence of two reactive amino groups that must be differentially protected during solid-phase peptide synthesis (SPPS). Commercial suppliers offer specialized derivatives such as Dde-DAB(Fmoc)-OH (CAS 1263045-85-7), which features both Dde and Fmoc protecting groups. This orthogonal protection scheme allows for selective deprotection of the N-terminal Fmoc group during chain assembly while maintaining the Dde protection on the side chain amino group. Consequently, researchers can achieve site-specific functionalization of the DAB residue after peptide synthesis is complete, enabling the creation of branched peptides, cyclic structures, or conjugates with fluorophores or other probes.

Formation of Conformationally Constrained Peptides

DAB serves as an exceptional building block for introducing conformational constraints into peptide structures. When incorporated into peptide sequences, the gamma amino group can participate in cyclization reactions to form 5-membered lactam rings. Research has demonstrated that Boc derivatives of 2,4-diaminobutyric acid can be used to synthesize cyclic dipeptides that serve as substrates for incorporation into proteins using modified ribosomal systems. These conformationally constrained analogues provide valuable tools for studying protein folding, enzyme-substrate interactions, and the structural requirements for biological activity. The ability to lock peptides into specific conformations through DAB-mediated cyclization has important implications for drug discovery and the development of peptide-based therapeutics.

Dab
Dde-DAB(Fmoc)-OH

Biological Significance and Pharmacological Activity of DAB

Interaction with GABAergic Systems

One of the most extensively studied biological activities of DAB relates to its interaction with the GABA neurotransmitter system. As a structural analogue of gamma-aminobutyric acid, DAB acts as an inhibitor of sodium-dependent GABA uptake in neuronal tissues. This property has made DAB-containing peptides valuable pharmacological tools for investigating GABAergic neurotransmission and developing potential therapeutic agents for neurological disorders. The stereospecificity of this inhibition, with the S(+) isomer being substantially more potent, highlights the importance of chiral purity in DAB-based research compounds.

Anticancer Properties

Emerging evidence suggests that DAB possesses antitumoral activity, particularly against glioma cells. The compound is transported into cells by the System A amino acid transporter, and its concentrated uptake in glioma cells can lead to osmotic lysis. This mechanism exploits the enhanced metabolic demands of cancer cells and their increased expression of amino acid transporters. The potential for DAB to serve as a selective anticancer agent, especially against brain tumors, represents an exciting avenue for therapeutic development. Researchers exploring this application rely on custom peptide synthesis services to create DAB-containing compounds with optimized pharmacokinetic properties.

Find out about high-speed RUSH synthesis.

Frequently Asked Questions (FAQ)

What is the difference between 2,4-diaminobutyric acid and ornithine?

Both are diamino acids, but they differ in chain length. 2,4-Diaminobutyric acid (DAB) has a four-carbon backbone with amino groups at positions 2 and 4, whereas ornithine has a five-carbon backbone with amino groups at positions 2 and 5. This structural difference affects the ring size when forming cyclic derivatives. DAB forms 5-membered lactams, while ornithine forms 6-membered rings.

Why is orthogonal protection necessary for DAB in peptide synthesis?

DAB contains two chemically similar amino groups that must be selectively deprotected during SPPS. Orthogonal protecting groups like Dde and Fmoc allow researchers to remove one protecting group without affecting the other, enabling precise control over where modifications occur. This is essential for creating branched peptides, cyclic structures, or site-specifically labeled conjugates.

Can DAB be incorporated into peptides for therapeutic applications?

Yes, DAB-containing peptides have shown promise in various therapeutic contexts, particularly as anticancer agents targeting glioma cells and as pharmacological tools for studying GABAergic neurotransmission. However, researchers must carefully consider the stereoisomer used, as biological activity differs dramatically between L- and D-forms.

How does DAB affect peptide conformation?

The dual amino groups of DAB enable the formation of intramolecular lactam bridges, creating conformationally constrained cyclic peptides. These constraints can stabilize specific secondary structures, such as turns or helices, and provide insights into the bioactive conformations required for target interactions.


JOHNSTON, G. A. R., & TWITCHIN, B. (1977). STEREOSPECIFICITY OF 2,4‐DIAMINOBUTYRIC ACID WITH RESPECT TO INHIBITION OF 4‐AMINOBUTYRIC ACID UPTAKE AND BINDING. British Journal of Pharmacology, 59(1), 218–219. https://doi.org/10.1111/j.1476-5381.1977.tb06998.x

Zhang, C., Bai, X., Dedkova, L. M., & Hecht, S. M. (2020). Protein synthesis with conformationally constrained cyclic dipeptides. Bioorganic & Medicinal Chemistry, 28(22), 115780. https://doi.org/10.1016/j.bmc.2020.115780

Batoon, P., & Ren, J. (2015). Proton affinity of dipeptides containing alanine and diaminobutyric acid. International Journal of Mass Spectrometry, 378, 151–159. https://doi.org/10.1016/j.ijms.2014.07.025

Abz Fluorescent Labeling in Peptides

Posted on by
Abz
2-Aminobenzoyl Chloride

Fluorescent Labeling with Abz, where Abz stands for 2-aminobenzoyl, is an indispensable technique in biochemical and pharmacological research, particularly for studying enzyme kinetics and protein interactions. As a highly efficient fluorescent donor, Abz is renowned for its optimal spectral properties, including significant Stokes shift and high quantum yield, which facilitate sensitive detection in complex biological matrices. Its primary utility lies in Fluorescence Resonance Energy Transfer (FRET)-based assays, where it is paired with quenchers like 3-nitro-tyrosine (Tyr(NO2)) or 2,4-dinitrophenyl (Dnp) to create sensitive substrates for proteolytic enzymes. Consequently, this powerful labeling strategy enables real-time monitoring of protease activity, precise determination of kinetic parameters, and high-throughput screening of potential therapeutic inhibitors.

Key Takeaways

  • Abz is an excellent fluorescent donor in FRET systems owing to its favorable photophysical properties, including a high quantum yield and a favorable Stokes shift.
  • It is most commonly used in donor-quencher pairs (e.g., Abz/Dnp or Abz/Tyr(NO2)) to create fluorogenic substrates for monitoring protease activity.
  • Fluorescence quenching in these substrates is relieved upon enzymatic cleavage, generating a measurable increase in fluorescence intensity.
  • Abz-labeled peptides are crucial tools for studying enzymes like ACE (Angiotensin-Converting Enzyme) and various matrix metalloproteinases (MMPs).
  • The site-specific incorporation of Abz during solid-phase peptide synthesis (SPPS) allows for the custom design of sensitive and specific assay probes.

Fundamentals of the Abz Fluorophore

Chemical Structure and Spectral Properties

The 2-aminobenzoyl (Abz) group is a derivative of anthranilic acid. Its structure features an aromatic benzene ring coupled with an electron-donating amino group, which is responsible for its strong fluorescence. Abz is typically excited in the near-ultraviolet to blue region, with a maximum absorbance around 320 nm, and emits blue fluorescence with a peak around 420 nm. This separation between excitation and emission wavelengths, known as the Stokes shift, is advantageous as it minimizes interference from scattered excitation light, thereby enhancing signal-to-noise ratios in assays.

The Principle of FRET and Quenching

The exceptional utility of Abz arises from its role in fluorescence quenching mechanisms. In a typical application, the Abz fluorophore is chemically incorporated into a peptide sequence at one site, while a suitable quencher molecule is attached at another. When in close proximity, the energy from the excited Abz is non-radiatively transferred to the quencher, resulting in low background fluorescence. This intact, quenched molecule serves as a fluorogenic substrate. Upon cleavage by a specific protease at the site between the donor and quencher, the physical separation disrupts the energy transfer. This disruption leads to a dramatic increase, often a 20 to 30-fold enhancement, in Abz fluorescence, which can be monitored in real-time.

Find out more about fluorescent peptides here.

Primary Applications in Biomedical Research

Monitoring Protease Activity and Kinetics

Abz-based fluorogenic substrates are a gold standard for studying proteolytic enzymes. The design is versatile: a target protease’s cleavage sequence is flanked by the Abz donor and an appropriate quencher. For example, substrates like Abz-FRK(Dnp)P-OH are specifically designed for the enzyme ACE (Angiotensin-Converting Enzyme), a key target in hypertension and heart failure research. The real-time increase in fluorescence directly correlates with enzyme activity, allowing researchers to calculate critical kinetic parameters, such as the Michaelis constant (Km) and the catalytic rate constant (kcat), with high precision and sensitivity.

High-Throughput Drug Screening

The sensitivity and adaptability of Abz-based assays make them ideal for high-throughput screening (HTS) platforms in drug discovery. Pharmaceutical companies and research laboratories routinely use these substrates to screen vast chemical libraries for potential inhibitors of disease-relevant proteases. Targets include renin (involved in blood pressure regulation), beta-secretase (BACE-1) (implicated in Alzheimer’s disease), and various cathepsins and matrix metalloproteinases (MMPs) associated with cancer metastasis and inflammatory diseases. The homogeneous, “mix-and-read” format of these assays significantly accelerates the discovery of lead compounds.

Investigating Protein-Protein Interactions

Beyond simple cleavage assays, the Abz fluorophore can be used in more sophisticated FRET-based binding studies. In this context, Abz is attached to one protein, while a compatible acceptor fluorophore (not a quencher) is attached to its binding partner. A change in FRET efficiency signals a binding event or a conformational change. This application is powerful for characterizing antibody-antigen interactions, studying receptor-ligand dynamics, and probing structural changes within large protein complexes.

Synthesis and Implementation

Incorporation into Peptide Sequences

The integration of the Abz group into peptides is achieved through standard solid-phase peptide synthesis (SPPS) protocols. Special Fmoc-protected Abz derivatives are commercially available and function like standard amino acids during the synthesis cycle. This allows for precise, site-specific incorporation at the N-terminus, the C-terminus, or even at internal positions within the peptide chain, providing immense flexibility in probe design. Specialized service providers, such as LifeTein, offer custom peptide synthesis with Abz and various quenchers, enabling researchers to obtain high-purity, assay-ready substrates without the need for in-house synthetic expertise.

Designing an Effective Substrate

Creating an optimal Abz-labeled substrate requires careful consideration:

  1. Selection of Quencher: The quencher must have a strong spectral overlap with Abz’s emission. Dnp and Tyr(NO2) are classic, effective, and economical choices.
  2. Cleavage Sequence: The peptide linker must contain the specific recognition and cleavage sequence for the target enzyme.
  3. Length and Flexibility: The peptide must be long enough to allow efficient FRET when intact but should not hinder enzyme access to the cleavage site.

Find out more about peptide synthesis here.

Frequently Asked Questions (FAQ)

What does “Abz” stand for in peptide labeling?

Abz is the standard abbreviation for 2-aminobenzoyl, a fluorescent aromatic group derived from anthranilic acid. It functions as a highly efficient donor fluorophore in fluorescence-based assays.

How does an Abz/Dnp-labeled peptide work in a protease assay?

In an Abz/Dnp-labeled peptide, the Dnp group acts as a quencher for Abz fluorescence via FRET. When the intact peptide is excited, minimal fluorescence is detected. Upon cleavage by a specific protease between the two labels, they separate, FRET is abolished, and a strong increase in Abz fluorescence occurs, providing a direct measure of protease activity.

What are the main advantages of using Abz over other fluorophores like FAM or FITC?

Abz offers several key advantages: its larger Stokes shift reduces spectral interference, it is generally more photostable than fluorescein derivatives, and its excitation in the UV range can minimize background autofluorescence from biological samples, which is often excited at higher wavelengths.

Karaseva, M. A., Chukhontseva, K. N., Lemeskina, I. S., Pridatchenko, M. L., Kostrov, S. V., & Demidyuk, I. V. (2019). An Internally Quenched Fluorescent Peptide Substrate for Protealysin. Scientific Reports, 9(1). https://doi.org/10.1038/s41598-019-50764-2

Bernegger, S., Brunner, C., Vizovišek, M., Fonovic, M., Cuciniello, G., Giordano, F., Stanojlovic, V., Jarzab, M., Simister, P., Feller, S. M., Obermeyer, G., Posselt, G., Turk, B., Cabrele, C., Schneider, G., & Wessler, S. (2020). A novel FRET peptide assay reveals efficient Helicobacter pylori HtrA inhibition through zinc and copper binding. Scientific Reports, 10(1). https://doi.org/10.1038/s41598-020-67578-2